TD Asset Management Inc Buys 5,130 Shares of Tenet Healthcare Corporation $THC

TD Asset Management Inc lifted its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 4.2% during the 4th quarter, HoldingsChannel reports. The firm owned 126,882 shares of the company’s stock after acquiring an additional 5,130 shares during the period. TD Asset Management Inc’s holdings in Tenet Healthcare were worth $25,214,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in THC. Boston Partners grew its stake in shares of Tenet Healthcare by 38.8% during the third quarter. Boston Partners now owns 3,147,555 shares of the company’s stock worth $638,958,000 after buying an additional 880,413 shares during the last quarter. Ameriprise Financial Inc. lifted its stake in shares of Tenet Healthcare by 8.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after acquiring an additional 157,109 shares during the last quarter. AQR Capital Management LLC boosted its holdings in shares of Tenet Healthcare by 62.3% during the 3rd quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock valued at $380,989,000 after acquiring an additional 720,160 shares in the last quarter. Norges Bank acquired a new position in Tenet Healthcare in the 4th quarter worth about $248,494,000. Finally, Eminence Capital LP bought a new position in Tenet Healthcare in the third quarter valued at about $225,263,000. Institutional investors and hedge funds own 95.44% of the company’s stock.

Insider Activity at Tenet Healthcare

In other news, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the sale, the executive vice president owned 29,291 shares in the company, valued at $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the completion of the transaction, the director owned 16,804 shares in the company, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 15,138 shares of company stock valued at $3,065,789 in the last three months. Corporate insiders own 0.97% of the company’s stock.

Wall Street Analyst Weigh In

THC has been the topic of several research reports. KeyCorp reduced their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating on the stock in a report on Friday, May 1st. Guggenheim cut their target price on shares of Tenet Healthcare from $283.00 to $252.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Jefferies Financial Group upped their price target on shares of Tenet Healthcare from $250.00 to $265.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Finally, Royal Bank Of Canada decreased their price objective on Tenet Healthcare from $277.00 to $236.00 and set an “outperform” rating for the company in a report on Friday, May 1st. Eighteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $162.20 on Monday. The stock has a market capitalization of $13.97 billion, a price-to-earnings ratio of 8.43, a PEG ratio of 1.33 and a beta of 1.28. Tenet Healthcare Corporation has a 52-week low of $146.60 and a 52-week high of $247.21. The stock’s 50 day moving average price is $186.17 and its two-hundred day moving average price is $200.80. The company has a debt-to-equity ratio of 1.96, a quick ratio of 1.30 and a current ratio of 1.36.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.39 billion. During the same period last year, the company posted $4.36 earnings per share. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. On average, equities analysts predict that Tenet Healthcare Corporation will post 17.61 earnings per share for the current year.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.